Clinical activity of afatinib (BIBW 2992) in patients with lung adenocarcinoma with mutations in the kinase domain of HER2/neu von De Grève, J, Teugels, E, Geers, C, Decoster, L, Galdermans, D, De Mey, J, Everaert, H, Umelo, I, Veld, P. In’t, Schallier, D

Volltext

Frequent incidence of BARD1-truncating mutations in germline DNA from triple-negative breast cancer patients von De Brakeleer, S., De Grève, J., Desmedt, C., Joris, S., Sotiriou, C., Piccart, M., Pauwels, I., Teugels, E.

Volltext

MC13-0040 A novel HER3-V855A driver mutation homologous to EGFR-L858R in lung cancer von Umelo, I, Noeparast, A, Chen, G, Renard, M, Geers, C, Vansteenkiste, J, Teugels, E, De Greve, J

Volltext

Geographical distribution of Slovenian BRCA1/2 families according to family origin: implications for genetic screening von Krajc, M, Zadnik, V, Novaković, S, Stegel, V, Teugels, E, Bešič, N, Hočevar, M, Vakselj, A, De Grève, J, Žgajnar, J

Volltext

The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation von Sermijn, E, Goelen, G, Teugels, E, Kaufman, L, Bonduelle, M, Neyns, B, Poppe, B, De Paepe, A, De Grève, J

Volltext

Accurate KRAS mutation testing for EGFR-targeted therapy in colorectal cancer: emphasis on the key role and responsibility of pathologists von HOORENS, A, JOURET-MOURIN, A, SEMPOUX, C, DEMETTER, P, DE HERTOGH, G, TEUGELS, E

Volltext

206 The cis/trans effect of the T790M drug resistant mutation in non-small cell lung cancer von Umelo, I, Chen, G, Teugels, E, De Grève, J

Volltext

204 Effects of EGFR inhibition with tyrosine kinase inhibitors on invasive properties of EGFR mutant and wild type lung cancer cells von Umelo, I.A, De Wever, O, Teugels, E, Bracke, M, De Grève, J

Volltext

LBA2Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to Dabrafenib or Trametinib von Noeparast, A, Verschelden, G, Umelo, I, de Brakeleer, S, Decoste, L, Teugels, E, de Greve, J

Volltext

Investigation of non-V600 BRAF mutations commonly found in NSCLC for their sensitivity to Dabrafenib or Trametinib von Noeparast, A., Verschelden, G., Umelo, I., de Brakeleer, S., Decoste, L., Teugels, E., de Greve, J.

Volltext

High frequency of BRCA1/2 germline mutations in 42 Belgian families with a small number of symptomatic subjects von Goelen, G, Teugels, E, Bonduelle, M, Neyns, B, De Grève, J

Volltext

Transduction of ovarian cancer cells: a recombinant adeno-associated viral vector compared to an adenoviral vector von VERMEIJ, J, ZEINOUN, Z, NEYNS, B, TEUGELS, E, BOURGAIN, C, DE GREVE, J

Volltext

Abstract PD7-04: Exome based germline mutation detection in a panel of 372 cancer associated genes in BRCA1/2-negative familial breast cancer patients von Shahi, RB, Caljon, B, De Brakeleer, S, Decoster, L, Fontaine, C, Vanacker, L, Vanhoeij, M, Pauwels, I, Bonduelle, M, Vandooren, S, Croes, D, Teugels, E, De Greve, J

Volltext

Loss of nuclear BRCA1 localization in breast carcinoma is age dependent von BOGDANI, Marika, TEUGELS, E, DE GREVE, J, BOURGAIN, C, NEYNS, B, PIPELEERS-MARICHAL, M

Volltext

A Novel HER3/ERBB3 Driver Mutation in Non-Small Cell Lung Cancer von Umelo, I.A., Noeparast, A., Chen, G., Renard, M., Geers, C., Vansteenkiste, J., Teugels, E., de Grève, J.

Volltext

9166 Activity of BIBW 2992, an irreversible inhibitor of EGFR and HER2, in adenocarcinoma of the lung with HER2neu kinase domain mutations von De Greve, J, Teugels, E, Geers, C, DeMey, J, in 'tveld, P, Decoster, L, Taton, M, Shahidi, M, Galdermans, D, Schallier, D

Volltext

Identification of NPM1 as a potential high-penetrance gene in hereditary breast cancer von Ren, Z, Teugels, E, De Brakeleer, S, Sermijn, E, Bonduelle, M, Fontaine, C, De Greve, J

Volltext

Familial Cancer and ARLTS1 von De Brakeleer, Sylvia, Teugels, Erik, De Grève, Jacques, Frank, Bernd, Klaes, Rüdiger, Burwinkel, Barbara, Calin, George Adrian, Croce, Carlo M, Neuberg, Donna

Volltext

First-line erlotinib in advanced non-small cell lung cancer (NSCLC) carrying an activating EGFR mutation: A multicenter academic phase II study in Caucasian patients (pts) (NCT0033... von De Greve, J., Van Meerbeeck, J. P., Vansteenkiste, J. F., Teugels, E., Geers, C., Meert, A., Vuylsteke, P., Focan, C. N. J., Canon, J., Humblet, Y., Berchem, G. J., Colinet, B., Galdermans, D., Bosquée, L., Dooms, C. A., Decoster, L., Vermeij, J., Dewaele, A., Schallier, D. C. C.

Volltext

Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers von De Brakeleer, S, Bogdani, M, De Greve, J, Decock, J, Sermijn, E, Bonduelle, M, Goelen, G, Teugels, E

Volltext